hyperrab solution for infiltration & intramuscular injection
grifols asia pacific pte. ltd. - rabies immune globulin (human) - injection - 150 iu/ml - rabies immune globulin (human) 300 iu/ml
hyperrab sd
padagis israel agencies ltd, israel - rabies immunoglobulin - solution for injection - rabies immunoglobulin 150 iu/ml - rabies immunoglobulin - rabies immunoglobulin - to be given in conjunction with rabies vaccine as promptly as possible after exposure.
hyperrab s/d solution
grifols therapeutics llc - rabies immunoglobulin (human) - solution - 150unit - rabies immunoglobulin (human) 150unit - serums
hyperrab s/d (rabies immune globulin- human injection
grifols usa, llc - human rabies virus immune globulin (unii: 95f619atq2) (human rabies virus immune globulin - unii:95f619atq2) - human rabies virus immune globulin 150 [iu] in 1 ml - rabies vaccine and hyperrab s/d should be given to all persons suspected of exposure to rabies with one exception: persons who have been previously immunized with rabies vaccine and have a confirmed adequate rabies antibody titer should receive only vaccine. hyperrab s/d should be administered as promptly as possible after exposure, but can be administered up to the eighth day after the first dose of vaccine is given. recommendations for use of passive and active immunization after exposure to an animal suspected of having rabies have been detailed by the u.s. public health service advisory committee on immunization practices (acip). [19] every exposure to possible rabies infection must be individually evaluated. the following factors should be considered before specific antirabies treatment is initiated: carnivorous wild animals (especially skunks, foxes, coyotes, raccoons, and bobcats) and bats are the animals most commonly infected with rabies and have caused most of the indigenous cases of human rabies
rhinogard bovine herpesvirus 1 live intranasal liquid vaccine for cattle
zoetis australia pty ltd - bovine herpesvirus 1 - topical aerosol spray - bovine herpesvirus 1 vaccine-viral active 0.0 p - immunotherapy - cattle - feedlot | beef | bovine | dairy cow - bovine herpesvirus | promote animal growth | feed conversion | finishing | growth promotion | growth rate | liveweight gain
equivac hev hendra virus vaccine for horses
zoetis australia pty ltd - g glycoprotein of hendra virus (sg - protein); thiomersal - misc. vaccines or anti sera - g glycoprotein of hendra virus (sg - protein) vaccine-viral active 100.0 ug; thiomersal mercury other 0.1 mg/ml - immunotherapy
kollsut gilza™ polydioxanone absorbable synthetic sutures
kollsut singapore pte. ltd. - general hospital - gilza sutures are intended for use in general soft tissue approximation. these sutures are particularly useful where the combination of an absorbable suture and extended wound support (up to six weeks) is desirable. sterilization method is eo.
kollsut international pidilen™ polypropylene non-absorbable synthetic sutures
kollsut singapore pte. ltd. - general & plastic surgery - pidilen™ suture is indicated for use in general soft tissue approximation and/or ligation, including use in cardiovascular, ophthalmic and neurological procedures.
kollsut international silda™ silk braided non-absorbable synthetic sutures
kollsut singapore pte. ltd. - general hospital - silda suture is indicated for use in general soft tissue approximation and/or ligation for short term use (within 30 days).
kollsut radik™ (polyglactin 910-pgla) absorbable synthetic sutures
kollsut singapore pte. ltd. - general & plastic surgery - radik™ sutures are intended for use in general soft tissue approximation and/or ligation, including use in ophthalmic surgery.